Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2025Gastrointestinal DisordersOpen Access

Inflammatory Bowel Disease and Pharmacotherapeutic Treatment for Healthcare Providers: A Pedagogic Tutorial

View Full Paper
Ask AI
Bookmark
Share

Authors

CSCharlotte SilvestreJAJulien AntihBPBaptiste Perrier

Discussion

Loading...

Member takes

Overview

Review reveals treatment options and strategies for managing inflammatory bowel disease, highlighting patient monitoring and pharmacogenomics.

Key Points

  • Inflammatory bowel disease presents significant health challenges, affecting treatment options and patient quality of life.
  • Current treatments like anti-TNFα and JAK inhibitors relieve symptoms but do not cure IBD-related conditions.
  • Advancements in drug delivery systems aim to enhance treatment effectiveness while minimizing adverse effects on patients.
  • Greater clarity on treatment options can improve healthcare providers' ability to manage IBD effectively.

Cite This Study

Silvestre et al. (2025) studied this question.

synapsesocial.com/papers/68d43c79713b0b5dfea7bdaahttps://doi.org/10.3390/gidisord7030058
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Future of inflammatory bowel disease treatment: A review of novel treatments beyond guidelines2025 · 2 citations
  2. 2Revolutionizing IBD therapy: Insights into contemporary treatment strategies2025 · 7 citations
  3. 3Positioning and sequencing of advanced therapies in inflammatory bowel disease: A guide for clinical practice2025 · 9 citations
  4. 4Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review2025 · 36 citations
  5. 5A New Paradigm for Precision Drug Delivery in Inflammatory Bowel Disease: Effective Transfer, Enhanced Retention, and Pathology‐Targeting Treatment via Biomaterials and Engineered Platforms2025 · 8 citations